A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder

European Psychiatry

Volumn 23, Issue 8, 2008, Pages 567-574

  Knijnik, Daniela Z ^a   Blanco, Carlos ^b   Salum, Giovanni Abrahão ^a   Moraes, Carolina U ^a   Mombach, Clarissa ^a   Almeida, Ellen ^a   Pereira, Marília ^a   Strapasson, Atahualpa ^a   Manfro, Gisele G ^a   Eizirik, Cláudio L ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Anxiety disorders; Anxiolytics; Psychodynamic therapy; Social anxiety disorder; Social phobia; Treatment

Indexed keywords

CLONAZEPAM;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENERALIZED ANXIETY DISORDER; GROUP THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOTHERAPY; QUALITY OF LIFE; SOCIAL PHOBIA; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-ANXIETY AGENTS; CLONAZEPAM; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBJECT ATTACHMENT; PERSONALITY ASSESSMENT; PHOBIC DISORDERS; PILOT PROJECTS; PSYCHOANALYTIC THERAPY; PSYCHOTHERAPY, GROUP; YOUNG ADULT;

EID: 56649103708     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2008.05.004     Document Type: Article

References (61)

1. Alnaes R. Social phobia: research and clinical practice. Nord J Psychiatry 55 6 (2001) 419-425
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
3. Amorim P. Mini international neuropsychiatric interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr 22 3 (2000) 106-115
4. Baker S.L., Heinrichs N., Kim H.J., and Hoffmann S.G. The Liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis. Behav Res Ther 40 6 (2002) 701-715
5. Barlow D.H., Gorman J.M., Shear K.M., and Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial [published erratum appears in JAMA 2000;284(19):2450 and JAMA 2001;284(20):2597]. JAMA 283 19 (2000) 2529-2536
6. Beck A.T., Ward C.H., Mendolson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 567-571
7. Blanco C., Schneier F., Schmidt A., Blanco-Jerez C., Marshall R., Sánchez-Lacay A., et al. Pharmacological treatment of social anxiety disorder: a meta-analysis. Depress Anxiety 18 1 (2003) 29-40
8. Callahan K.L., Price J.L., and Hilsenroth M.J. A review of interpersonal-psychodynamic group psychotherapy outcomes for adult survivors of childhood sexual abuse. Int J Group Psychother 54 4 (2004) 491-519
9. Connor K.M., Davidson J.R., Potts N.L., Tupler L.A., and Miner C. Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol 18 5 (1998) 373-378
10. Cox B.J., Ross L., Swinso R.P., and Direnfeld D.M. A comparison of social phobia outcome measures in cognitive-behavioral group therapy. Behav Modif 22 3 (1998) 285-297
11. Crestana T., Hauck S., Almeida E.A., Momback C.K., Campos C.P., Pereira M.P., et al. Instrumento para avaliação de sessões de psicoterapia analítica. Rev Bras Psiq 29 Supl. esp. (2005) S62
12. Davidson J.R., Ford S.M., Smith R.D., and Potts N.L. Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 52 Suppl (1998) 16-20
13. Davidson J.R., and Moroz G. Pivotal studies of clonazepam in panic disorder. Psychopharmacol Bull 34 2 (1998) 169-174
14. Davidson J.R., Potts N., Richichi E., Krishnan R., Ford S.M., Smith R., et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13 6 (1993) 423-428
15. Davidson J.R. Pharmacotherapy of social anxiety disorder: what does the evidence tell us?. J Clin Psychiatry 67 Suppl 12 (2006) 20-26
16. Davidson J.R.T., Foa E.B., and Huppert J.D. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 61 10 (2004) 1005-1013
17. Fedoroff I.C., and Taylor S.T. Psychological and pharmachological treatments of social phobia: a meta-analysis. Behav Ther 23 (2001) 695-720
18. Fleck M.P.A., Leal O.F., Louzada S., Xavier M., Chachamovich E., Vieira G., et al. O instrumento de avaliação de qualidade de vida abreviado da Organização Mundial da Saúde (WHOQOL-breve): Aplicação da versão em português. Rev Saúde Pública 34 2 (2000) 178-183
19. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 162 1 (2005) 151-161
20. Fonagy P., Roth A., and Higgitt A. Psychodynamic psychotherapies: evidence-based practice and clinical wisdom. Bull Menninger Clin 69 1 (2005) 1-58
21. Frances A., and Nemiah J.C. Which psychodynamic therapy for painfully shy patient?. Hosp Comm Psychiat 34 12 (1983) 1111-1117
22. Fresco D.M., Coles M.E., Heimberg R.G., Liebowitz M.R., Hami S., Stein M.B., et al. The Liebowitz social anxiety scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychol Med 31 6 (2001) 1025-1035
23. Freud S. The interpretation of dreams. In: Strachey J. (Ed). The standard edition of the complete psychological works of Sigmund Freud (1953), Hogarth Press, London 1-627
24. Gabbard G.O. Psychodynamics of panic disorder and social phobia. Bull Meninger Clin 56 Suppl A (1992) 3-13
25. Gould R.A., Buckminster S., Pollack M.H., Otto M.W., and Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clin Psychol Sci Prac 4 (1997) 291-306
26. Guy W. Assessment manual for psychopharmacology (1976), US Government Printing Office
27. Heimberg R.G., Dodge C.S., Hope D.A., Kennedy C.R., and Zolo L.J. Cognitive behavioral group treatment for social phobia: comparison with a credible placebo control. Cognit Ther Res 14 (1990) 1-23
28. Heimberg R.G., Liebowitz M.R., Hope D.A., Schneier F.R., Holt C.S., Welkowitz L.A., et al. Cognitive behavioral group therapy vs. phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry 55 12 (1998) 1133-1141
29. Hidalgo R.B., Barnett S.D., and Davidson J.R.T. Social anxiety disorder in review: two decades of progress. Int J Neuropsychopharmacol 4 3 (2001) 279-298 [Review]
30. Hollon S.D., Jarrett R.B., Nierenberg A.A., Thase M.E., Trivedi M., and Rush A.J. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?. J Clin Psychiatry 66 4 (2005) 455-468
31. Kaufman R.M. A clinical note on social anxiety. Psychoanal Rev 28 (1941) 72-77
32. Keller M.B., Mccullough J.P., Klein D.N., Arnow B., Dunner D.L., Gelenberg A.J., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342 20 (2000) 1462-1470 [published erratum appears in N Engl J Med 2001;345(3):232]
33. Knijnik D.Z., Kapczinski F.P., Chachamovich E., Margis R., and Eizirik C.L. Psychodynamic group treatment for generalized social phobia. Rev Bras Psiquiatr 26 2 (2004) 77-81
34. Lanza M. Assaultive behavior intervention in the Veterans Administration: psychodynamic group psychotherapy compared to cognitive behavior therapy. Perspect Psychiatr Care 38 3 (2002) 89-97
35. Leichsenring F., Hiller W., Weissberg M., and Leibing E. Cognitive-behavioral therapy and psychodynamic psychotherapy: techniques, efficacy, and indications. Am J Psychother 60 3 (2006) 233-259
36. Leichsenring F., Rabung S., and Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 61 (2004) 1208-1216
37. Leichsenring F. Are psychodynamic and psychoanalytic therapies effective?. Int J Psychoanal 86 Pt 3 (2005) 841-868
38. Liebowitz M.R., Mangano R.M., Bradwjen J., and Asnis G. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. J Clin Psychiatry 66 (2005) 238-247
39. Liebowitz M.R. Social phobia. Mod Probl Pharmacopsychiatry 22 (1987) 141-173
40. Lipsitz J.D., Gur M., Vermes D., Petkova E., Cheng J., Miller N., et al. A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depress Anxiety 25 6 (2008) 542-553
41. Lipsitz J.D., and Marshall R.D. Alternative psychotherapy approaches for social anxiety disorder. Psychiatr Clin North Am 24 4 (2001) 817-829
42. Malan D.H. The frontier of brief psychotherapy (1976), Plenum, New York
43. Milrod B., Leon A.C., Busch F., Shapiro T., Aronson A., Roiphe J., et al. A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 164 2 (2007) 265-272
44. Montgomery S.A. Implications of the severity of social phobia. J Affect Disord 50 Suppl 1 (1998) 17-22
45. O'neil M.K. Psychodynamic group treatment of young adult bulimic women: preliminary positive results. Can J Psychiatry 32 2 (2007) 153-155
46. Otto M.W., Pollack M.H., Gould R.A., Worthington J.J., McCardle E.T., and Rosenbaum J.F. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. J Anxiety Disord 14 4 (2000) 345-358
47. Quitkin F.M., Rabkin J.D., Markowitz J.M., Stewart J.W., Mcgrath P.J., and Harrison W. Use of pattern analysis to identify true drug response. Arch Gen Psychiatry 44 3 (1987) 259-264
48. Robinson H., and Hood S. Social anxiety disorder: a review of pharmacological treatments. Cur Psych Rev 3 2 (2007) 95-122
49. Rodebaugh T.L., Holaway R.M., and Heimberg R.G. The treatment of social anxiety disorder. Clin Psychol Rev 24 7 (2004) 883-908
50. Rowa K., and Antony M.M. Psychological treatments for social phobia. Can J Psychiatry 50 6 (2005) 305-307
51. Schneier F.R. Social anxiety disorder. N Engl J Med 355 10 (2006) 1029-1036
52. Seedat S., and Stein M.B. Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder. J Clin Psychiatry 65 2 (2004) 244-248
53. Shapiro T. The concept of unconscious fantasy. J Clin Psychoanal 1 (1992) 517-524
54. Stewart J.W., Garfinkel R., Nunes E.V., Donavan S., and Klein D.F. Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 18 6 (1998) 429-434
55. Vaughan S.C., Marshall R.D., and Mackinnon R.A. Can we do psychoanalytic outcome research? A feasibility study. Int J Psychoanal 81 Pt 3 (2000) 513-527
56. Verbeke G., and Molenberghs G. Linear mixed models for longitudinal data (2007), Springer, New York
57. Versiani M., Nardi A.E., Figueira I., Menlowics M., and Marques C. Double-blind placebo controlled trial with bromazepam in social phobia. J Bras Psiq 46 (1997) 167-171
58. Versiani M., Nardi A.E., Petribu K.L., Figueira I., and Marques C. Clonazepam in social phobia. J Bras Psiq 46 (1997) 103-108
59. Wilberg T., Karterud S., Pedersen G., Urnes O., Irion T., Brabrand J., et al. Outpatient group psychotherapy following day treatment for patients with personality disorders. J Personal Disord 17 6 (2003) 510-521
60. Zaider T.I., and Heimberg R.G. Non-pharmacologic treatments for social anxiety disorder. Acta Psychiatr Scand 417 (2003) 72-84
61. Zerbe K.J. Uncharted waters: psychodynamics considerations in the diagnosis and treatment of social phobia. Bull Meninger Clin 58 Suppl A (1994) A3-A20